NYU Langone achieves highest-quality kidney and lung transplant results in the U.S.

The NYU Langone Transplant Institute had the highest-quality kidney and lung transplant outcomes in the nation in 2023, according to federal quality data, while its heart and liver transplant programs reached new heights last year.

Dementia Risk Linked With Cumulative Heartburn Med Use, Analysis Suggests

Cumulative use of proton pump inhibitors (PPIs) — drugs used to help control acid reflux and other gastrointestinal disorders — upped the risk of dementia,

August 10, 2023

FDA approves Amneal and Shilpa’s oncology product BORUZU

The product is intended to treat multiple myeloma and will be launched with a unique J-code in the second quarter of next year. Credit: Nemes

September 6, 2024

Year in Review: Atopic Dermatitis

New therapies, expanding uses for existing therapies, and links between atopic dermatitis (AD) and multiple inflammatory conditions have made headlines so far this year. IL-13

November 2, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.